Biochemical and cellular characterization of the interplay between glutamine metabolism, mTOR and Notch1 signaling in cancer therapy

Biochemical and cellular characterization of the interplay between glutamine metabolism, mTOR and Notch1 signaling in cancer therapy

La tumorigenèse est un processus multi-étapes, constituée d'altérations génétiques qui conduisent à la transformation maligne des cellules humaines normales. Au cours de cette transformation maligne, l’activité de différentes voies oncogéniques est augmentée. Les voies de signalisation mTORC1 e...

Full description

Bibliographic Details
Main Author:	Nguyen, Tra ly
Other Authors:	Bordeaux
Language:	en
Published:	2018
Subjects:	MTOR Notch1 Glutamine Métabolisme Cancer Thérapie Metabolism Therapy
Online Access:	http://www.theses.fr/2018BORD0053

Similar Items

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia
by: Tra Ly Nguyen, et al.
Published: (2021-05-01)

Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer
by: Man Tong, et al.
Published: (2021-08-01)

Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism
by: Yi Ding, et al.
Published: (2021-04-01)

PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
by: Fatmah A. Mansour, et al.
Published: (2020-01-01)

Chemopreventive Effect of Dietary Glutamineon Colitis-Associated Colorectal Cancer Is Associated with Modulation of the DEPTOR/mTOR Signaling Pathway
by: Yun Tian, et al.
Published: (2016-05-01)

GOLM1 Stimulation of Glutamine Metabolism Promotes Osteoporosis via Inhibiting Osteogenic Differentiation of BMSCs
by: Guangsi Shen, et al.
Published: (2018-11-01)

Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma
by: Li-Zhi Wu, et al.
Published: (2021-01-01)

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
by: Diane M. Demas, et al.
Published: (2019-08-01)

LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma
by: Hou G, et al.
Published: (2019-07-01)

Implication de la glutamine dans l’activation de mTORC1 dans les leucémies aiguës myéloïdes et inhibition ciblée
by: Willems, Lise
Published: (2012)

Rôle fonctionnel des pentoses phosphates et glutamine dans le métabolisme des cellules cancéreuses
by: Polat, Ibrahim Halil
Published: (2016)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

The oncogenic role of Jagged1/Notch signaling in cancer
by: Meng-xi Xiu, et al.
Published: (2020-09-01)

Hepatitis C virus-induced reprogramming of glutamine metabolism
by: Lévy, Pierre
Published: (2014)

Glutamine relieves oxidative stress through PI3K/Akt signaling pathway in DSS-induced ulcerative colitis mice
by: Shuguang Yan, et al.
Published: (2020-09-01)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
by: Tian Tian, et al.
Published: (2019-02-01)

mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro
by: Sandra M. Ayuk, et al.
Published: (2019-05-01)

Targeting Glutamine Addiction in Gliomas
by: Marta Obara-Michlewska, et al.
Published: (2020-01-01)

Targeting mTOR for cancer therapy
by: Hui Hua, et al.
Published: (2019-07-01)

Unfolding the Mechanism of Notch1 Receptor Activation : Implications in Cancer Stem Cell Targeting
by: Sharma, Ankur
Published: (2018)

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
by: Olivier Dormond, et al.
Published: (2011-05-01)

Macrophage Stimulated by Low Ambient Temperature Hasten Tumor Growth via Glutamine Production
by: Eun-Ji Lee, et al.
Published: (2020-09-01)

Glutamine Synthetase as a Therapeutic Target for Cancer Treatment
by: Go Woon Kim, et al.
Published: (2021-02-01)

Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth
by: Martina Chiu, et al.
Published: (2018-04-01)

Tangeretin prevents prostate cancer cell proliferation and induces apoptosis via activation of Notch signalling and regulating the androgen receptor (AR) pathway and the phosphoinositide 3-kinase (PI3k)/Akt/mTOR pathways
by: Jin-Jin Guo, et al.
Published: (2015-11-01)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01)

Inhibition of Notch Signaling Promotes the Adipogenic Differentiation of Mesenchymal Stem Cells Through Autophagy Activation and PTEN-PI3K/AKT/mTOR Pathway
by: Bao-quan Song, et al.
Published: (2015-07-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
by: Antonio Gil-Gómez, et al.

Possible activation by the green tea amino acid theanine of mammalian target of rapamycin signaling in undifferentiated neural progenitor cells in vitro
by: Takeshi Takarada, et al.
Published: (2016-03-01)

The Role of mTOR Signaling as a Therapeutic Target in Cancer
by: Nadezhda V. Popova, et al.
Published: (2021-02-01)

Notch1-Induced Survival Signaling And Its Implications In Cancer Therapeutics
by: Mungamuri, Sathish Kumar
Published: (2009)

Implication de la pseudokinase dans la réponse aux inhibiteurs de mTor
by: Vicier, Cecile
Published: (2017)

Glutamine metabolism in the proliferation of GS-expression pituitary tumor cells
by: Jintao Hu, et al.
Published: (2020-03-01)

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

The Notch ligand Jagged1 as a target for anti-tumour therapy
by: Demin eLi, et al.
Published: (2014-09-01)

Les vulnérabilités métaboliques des cancers résistants au cisplatine
by: Obrist, Florine
Published: (2017)

mTOR: A Cellular Regulator Interface in Health and Disease
by: Fahd Boutouja, et al.
Published: (2019-01-01)

Glutamine regulates ovarian cancer cell migration and invasion through ETS1
by: Parash Prasad, et al.
Published: (2021-05-01)

Targeting the metabolic environment to modulate T cell effector function
by: Ferreira Matias, Maria
Published: (2019)